NCT02985099View on ClinicalTrials.gov

1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Chronic PeriodontitisType2 Diabetes
Interventions
DRUG

SRP plus Rosuvastatin gel

SRP followed by 1.2% Rosuvastatin placement into intrabony defect

DRUG

SRP plus placebo gel

SRP followed by placebo gel placement into intrabony defect

Trial Locations (1)

560002

Government Dental College and Research Institute, Bangalore

All Listed Sponsors
lead

Government Dental College and Research Institute, Bangalore

OTHER

NCT02985099 - 1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter